Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve Un-Audited Financial ....
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amrutanjan Health Care has informed BSE and NSE that its Board of Directors will meet on Monday, 10 November 2025 via video conferencing. The Board will consider and approve the Un-Audited Financial Results along with the Limited Review Report for the quarter and half-year ended 30 September 2025. Additionally, the Board will consider declaration of the 1st Interim Dividend for FY 2025-26. The trading window for dealing in the company's equity shares is already closed from 1 October 2025 and will reopen on 12 November 2025, as per SEBI insider trading norms.
This is a routine pre-results intimation. Investors should watch for the Q2 FY26 earnings on 10 November and any announcement on the interim dividend, which could be a positive catalyst for the stock in the short term.